Bicher Cancer Institute
Bicher Cancer Institute is one of America’s largest Hyperthermia research and clinical treatment centres. Since its foundation in 1984 by Dr James Haim Bicher, BCI has been committed to the research, development, and clinical use of Hyperthermia, a natural, less toxic chancroidal modality, to improve cancer treatment results while decreasing side effects of conventional therapies. The hyperthermia cancer treatment approach used at BCI has a curative intent, as opposed to palliative treatment used in conventional therapies like radiation alone, high toxic chemotherapy, and the “point of no return” surgery whose purpose is only to prolong patients’ lives. Hyperthermia cancer treatment in conjunction with low dose Intensity-Modulated Radiation Therapy (IMRT) offered at BCI, is purposely intended to cure when tumours are localized.